{"id":3230,"count":51,"description":"Katalog MedsBase Diabetes sdru\u017euje v\u0161echna l\u00e9\u010diva souvisej\u00edc\u00ed s diabetem nap\u0159\u00ed\u010d hlavn\u00edmi t\u0159\u00eddami l\u00e9k\u016f. Podrobn\u00fd klinick\u00fd p\u0159ehled podle molekulov\u00fdch rodin s \u00fapln\u00fdm seznamem zna\u010dek najdete v na\u0161em L\u00e9ky na diabetes<\/a> podkategorii \u2014 pros\u00edm, projd\u011bte si ji pro v\u00fdb\u011brov\u00e9 pokyny a d\u00e1vkovac\u00ed kontext. V\u0161echny produkty jsou dod\u00e1v\u00e1ny spole\u010dnost\u00ed WHO-GMP certifikovan\u00fdch v\u00fdrobc\u016f<\/strong>.\n\nShrnut\u00ed t\u0159\u00eddy l\u00e9k\u016f.<\/strong> Biguanidy (metformin \u2014 prvn\u00ed volba, Glycomet SR, Metford), sulfonylmo\u010doviny (gliclazid, glimepirid, glibenklamid, glipizid), inhibitory DPP-4 (sitagliptin Januvia, vildagliptin Galvus, saxagliptin Onglyza, linagliptin Trajenta, teneligliptin Ziten), inhibitory SGLT-2 (dapagliflozin Forxiga, empagliflozin Jardiance, canagliflozin Invokana \u2014 s p\u0159\u00ednosy kardio-ren\u00e1ln\u00ed ochrany), pioglitazon (Pioz), meglitinidy (repaglinid Novonorm, nateglinid Glinate), inhibitory alfa-glukosid\u00e1zy (akarb\u00f3za Glucobay, voglib\u00f3za Voglibite, miglitol Mignar) a rychle p\u016fsob\u00edc\u00ed inzul\u00ednov\u00e1 pera (inzul\u00edn aspart Novorapid Flexpen, inzul\u00edn glulisin Apidra SoloStar). Kombinovan\u00e9 terapie spojuj\u00edc\u00ed metformin se sulfonylmo\u010dovinou, inhibitorem DPP-4 nebo inhibitorem SGLT-2 sni\u017euj\u00ed po\u010det tablet u pacient\u016f s polyfarmakoterapi\u00ed.\n\nSpeci\u00e1ln\u00ed p\u0159\u00edpravky.<\/strong> Lipaglyn (saroglitar \u2014 du\u00e1ln\u00ed agonista PPAR \u03b1\/\u03b3 pro diabetickou dyslipid\u00e9mii a NASH) jako Lipaglyn<\/a>. Injekce methykobalaminu \/ kyanokobalaminu pro diabetickou neuropatii jako Methycobal Injekce<\/a>.\n\nCo zde NEN\u00cd.<\/strong> Agonist\u00e9 receptoru GLP-1 (semaglutid Ozempic, liraglutid Victoza, dulaglutid, tirzepatid) jsou skladov\u00e1ni samostatn\u011b jako sou\u010d\u00e1st na\u0161\u00ed nab\u00eddky pro \u0159\u00edzen\u00ed hmotnosti \u2014 viz Nejlep\u0161\u00ed alternativy Ozempicu 2026<\/a>. Dlouhodob\u011b p\u016fsob\u00edc\u00ed baz\u00e1ln\u00ed inzul\u00edny (inzul\u00edn glargin, degludek, detemir) jsou uvedeny v samostatn\u00fdch podkategori\u00edch inzul\u00ednu, pokud jsou skladem.\n\nRozli\u0161en\u00ed.<\/strong> Desmopresin (Minirin tablety, Minirin nosn\u00ed sprej) je v sou\u010dasnosti chybn\u011b za\u0159azen v na\u0161em katalogu diabetu. Desmopresin l\u00e9\u010d\u00ed diabetes insipidus<\/strong> (porucha ledvinov\u00e9ho hospoda\u0159en\u00ed s vodou) a no\u010dn\u00ed pomo\u010dov\u00e1n\u00ed\/nokturie \u2014 NE diabetes mellitus<\/strong> (b\u011b\u017en\u00fd diabetes 1. typu\/2. typu). Str\u00e1nky to explicitn\u011b vysv\u011btluj\u00ed. Pros\u00edm p\u0159esu\u0148te do kategorie mo\u010dov\u00fd m\u011bch\u00fd\u0159\/prostata\/urologie, jakmile bude vytvo\u0159ena samostatn\u00e1 kategorie pro no\u010dn\u00ed pomo\u010dov\u00e1n\u00ed.\n\nJak vybrat.<\/strong> Nov\u011b diagnostikovan\u00fd diabetes 2. typu \u2192 metformin jako prvn\u00ed volba (titrovat na 1,5\u20132 g\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch). Nedostate\u010dn\u00e1 kontrola p\u0159i metforminu \u2192 p\u0159idat inhibitor SGLT-2 (kardio-ren\u00e1ln\u00ed benefit) nebo inhibitor DPP-4 (neutr\u00e1ln\u00ed k v\u00e1ze) nebo sulfonylureu (nejlevn\u011bj\u0161\u00ed, riziko hypoglyk\u00e9mie). Prok\u00e1zan\u00e9 kardiovaskul\u00e1rn\u00ed onemocn\u011bn\u00ed nebo srde\u010dn\u00ed selh\u00e1n\u00ed \u2192 preferovat inhibitor SGLT-2 bez ohledu na HbA1c. V\u00fdrazn\u00e1 nadv\u00e1ha \u2192 SGLT-2 nebo GLP-1 RA. Riziko hypoglyk\u00e9mie (sta\u0159\u00ed, k\u0159ehc\u00ed, osam\u011bl\u00ed) \u2192 vyhnout se sulfonylure\u00e1m, preferovat inhibitory DPP-4 nebo SGLT-2. Diabetes 1. typu \u2192 baz\u00e1ln\u011b-bolov\u00fd inzulinov\u00fd re\u017eim (zahajuje specialista, zde nekatalogizov\u00e1no).\n\nD\u016fle\u017eit\u00e9.<\/strong> N\u00e1hl\u00e1 hyperglyk\u00e9mie s nevolnost\u00ed, zvracen\u00edm, bolest\u00ed b\u0159icha \u2192 zkontrolovat diabetickou ketoacid\u00f3zu (zejm\u00e9na u typu 1 nebo u\u017eivatele SGLT-2 inhibitor\u016f), urgentn\u00ed vy\u0161et\u0159en\u00ed. T\u011b\u017ek\u00e1 hypoglyk\u00e9mie se sn\u00ed\u017een\u00fdm v\u011bdom\u00edm \u2192 gluk\u00f3za\/glukagon, 999. Nov\u00e1 diagn\u00f3za nebo v\u00fdrazn\u00e1 zm\u011bna kontroly vy\u017eaduje monitorov\u00e1n\u00ed HbA1c po 3 m\u011bs\u00edc\u00edch. \u017divotn\u00ed styl (strava, hmotnost, aktivita, odvyk\u00e1n\u00ed kou\u0159en\u00ed, kontrola TK a lipid\u016f) z\u016fst\u00e1v\u00e1 z\u00e1kladem p\u00e9\u010de o v\u0161echny typy diabetu.\n\nV\u0161echny produkty MedsBase Diabetes se odes\u00edlaj\u00ed z WHO-GMP certifikovan\u00fdch v\u00fdrobc\u016f<\/strong> s diskr\u00e9tn\u00edm balen\u00edm a jsou kryty na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>.\n\nN\u00e1kupn\u00ed pr\u016fvodce 2026:<\/strong> Prohl\u00e9dn\u011bte si n\u00e1\u0161 v\u00fdb\u011br Nejlep\u0161\u00ed l\u00e9ky na diabetes 2026: 10 nejlep\u0161\u00edch v\u00fdb\u011br\u016f ve srovn\u00e1n\u00ed<\/a> pro se\u0159azen\u00e9 tipy, srovn\u00e1vac\u00ed tabulku, d\u00e1vkov\u00e1n\u00ed a zkratku k rozhodnut\u00ed.","link":"https:\/\/medsbase.com\/cs\/diabetes\/","name":"Diabetes","slug":"diabetes","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product?product_cat=3230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}